Ann Bevitt

Cooley advised Philochem AG, a wholly owned subsidiary of the Philogen Group (Milan Stock Exchange: PHIL), on its definitive license agreement with RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb (NYSE: BMY), granting RayzeBio exclusive worldwide rights to develop, manufacture and commercialize OncoACP3, a clinical-stage therapeutic and diagnostic agent targeting prostate cancer.

Cooley advised Autolus – a clinical-stage biopharmaceutical company developing next-generation programmed T-cell therapies – on its strategic collaboration with BioNTech, an immunotherapy company pioneering novel therapies for cancer and other serious diseases, to advance both companies’ autologous CAR-T programs toward commercialization, as well as a $350 million underwritten offering.

Cooley advised Moogsoft, an artificial intelligence-driven provider of intelligent monitoring solutions that support DevOps and ITOps, on its agreement to sell to Dell Technologies. Lawyers Steve Tonsfeldt, Mark Tanoury, Sangitha Palaniappa and Allison Peth led the Cooley team advising Moogsoft.

Read more

Cooley is advising Veritone, an artificial intelligence company, on its acquisition of Broadbean for $52 million.

Cooley advised the shareholders of ICS Learn, an online professional education platform owned by private equity firm Primary Capital Partners, on the platform’s sale to vocational e-learning provider Skill & You, a portfolio company of private equity firm IK Partners. Private equity partner Stephen Rosen led the Cooley team advising the shareholders of ICS Learn.